GL1X · GenesisL1 explorer

MolNFT v1 · #173980 · protein

Xfel structure of the ertapenem-derived ctx-M-15 acylenzyme after mixing for 2 sec using a piezoelectric injector (polypico)

7BH5 · Beta-lactamase: “Xfel structure of the ertapenem-derived ctx-M-15 acylenzyme after mixing for 2 sec using a piezoelectric…”. X-ray diffraction, 3 ligands (TVE, NA, CL), 1 pocket (best druggability 0.33). MolNFT v1 #173980 on…

PDB
7BH5
Type
protein
Length
259 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
G3G192
Ligands
TVE, NA, CL
Pockets
1 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein25944% helix, 19% strandG3G192

Ligands and binding sites

  • TVE · (2~{S},3~{R},4~{R})-3-[5-[(3-carboxyphenyl) carbamoyl]pyrrolidin-3-yl]sulfanyl-4-methyl-5-[(2~{S}, 3~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-3,4-dihydro-2~{H}-pyrrole-2-carboxylic acid · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.330.7523TVE

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7BH5 · XFEL structure of the ertapenem-derived CTX-M-15 acylenzyme after mixing for 2 sec using… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.